Clinical Trials Sponsored by Alberta Diabetes Institute

Total 3221 results

Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

T1DTechCHW: Enhancing the Community Health Worker Model to Promote Diabetes Technology Use in Young Adults From Underrepresented Minority Groups (T1DTechCHW)

Diabetes Mellitus | Diabetes | Type 1 Diabetes | Young Adult

United States
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

2-A-Day Study: Twice a Day Meals Study.

PreDiabetes

United States
National Institute of Diabetes and Digestive and...
Albert Einstein College of Medicine

Completed

Family Weight Management Study

Obesity | Diabetes

United States
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Trial of Hypofractionated Radiation Therapy for Glioblastoma

Glioblastoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Active, not recruiting

Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014

Neuroendocrine Tumors, NET

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside Analogs

Pancreatic Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Terminated

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Non-small Cell Lung Cancer | Advanced Solid Malignancies

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Withdrawn

An Imaging Study in Patients With Thyroid Cancer or Head and Neck Cancer With Pertechnetate Made in a Cyclotron (C-PERT)

Head and Neck Neoplasms | Thyroid Neoplasms
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

Study to See Whether Breath-Hold Techniques During RT Are Effective in Helping to Improve Sparing of the Heart

Breast Cancer | Adverse Effect of Radiation Therapy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Unknown

A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Glioma | Breast Cancer | Head and Neck Cancer | Carcinoma, Squamous Cell | Prostate Cancer | Carcinoma, Non-Small-Cell-Lung

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Phase I/II Study of Fractionated Stereotactic Radiotherapy for Early Stage Non-Small Cell Lung Cancer

Non-small Cell Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Pulse Sequence Development on 3T Magnetic Resonance Imaging/Spectroscopy

Healthy

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Phase II Trial of Consolidative Thoracic Radiotherapy for Extensive Stage Small Cell Lung Cancer

Extensive Stage Small Cel Lung Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect) (SUPER)

Heart Failure | Renal Cell Carcinoma | Hypertension | Cardiotoxicity

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Nutritional Status and Barriers to Dietary Intake in Head and Neck Cancer Patients

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Mathematical Modeling Analysis of Serum Prostate Specific Antigen After Radiotherapy

Prostate Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Xerostomia in Head and Neck Cancer Patients Receiving Radiation as the Primary Treatment Versus Patients Who Will Not Have Such a Procedure

Head and Neck Cancer

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

MVCT Imaging Pilot Study Using Helical Tomotherapy

Cancer, Carcinoma

Canada
AHS Cancer Control Alberta
Cross Cancer Institute

Completed

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Small Cell Carcinoma | Lung Neoplasm

Canada
Albert Einstein College of Medicine
Juvenile Diabetes Research Foundation; DexCom, Inc.

Recruiting

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression (UP-CBT)

Diabetes | Type 1 Diabetes

United States
Albert Einstein College of Medicine
Juvenile Diabetes Research Foundation; DexCom, Inc.

Recruiting

Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes (ReDUCe)

Type 1 Diabetes

United States
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

New Onset Type 1 Diabetes: Role of Exenatide

Type 1 Diabetes

United States
Baker Heart and Diabetes Institute

Recruiting

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

Heart Failure

Australia
Baker Heart and Diabetes Institute

Recruiting

Early Detection of Coronary Artery Disease by Polygenic and Metabolic Risk Scoring (EDCAD-PMS)

Coronary Artery Disease

Australia
Baker Heart and Diabetes Institute

Withdrawn

Study of High Dosage of Losartan in Comparison to Low Dose of Losartan in Heart Failure Patients

Heart Failure
Sansum Diabetes Research Institute
Sanofi

Completed

Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes

Diabetes During Pregnancy

United States
HealthPartners Institute
Abbott Diabetes Care

Completed

Establishing Ambulatory Glucose Profiles for People Without Diabetes Using CGM Data

Glucose Variability | CGM | NonDiabetes

United States
Albert B. Sabin Vaccine Institute

Completed

Development of a Skin Test for the Na-ASP-2 Hookworm Antigen

Allergy | Hookworm Infection

United States
University of Alberta
Ottawa Hospital Research Institute; University of Calgary; Alberta Innovates... and other collaborators

Completed

Primary Care Pathway for Childhood Asthma

Asthma

Canada
Dasman Diabetes Institute
Kuwait University; Ministry of Health, Kuwait; Texas Diabetes Institute

Unknown

Effect of Pioglitazone on T2DM Patients With COVID-19 (PIOQ8)

Covid19 | Type 2 Diabetes

Qatar, Kuwait
Alberta Health services
Canadian Institutes of Health Research (CIHR)

Terminated

Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

Neoplasms | Nausea

Canada
Baker Heart and Diabetes Institute

Not yet recruiting

Reducing Cognitive Impairment by Management of Heart Failure as a Modifiable Risk Factor (Cog-HF)

Heart Failure | Cognitive Impairment | Dementia | Cognitive Change | Cognitive Decline | Left Ventricular Dysfunction
Dasman Diabetes Institute
Kappa Bioscience

Recruiting

Vitamin K2 and Muscle Weakness in Type 2 Diabetes (SARK2)

Diabete Type 2

Kuwait
Baker Heart and Diabetes Institute

Completed

Effect of Ghrelin on Sympathetic Nervous System

Healthy | Obesity

Australia
Baker Heart and Diabetes Institute

Terminated

Renal Denervation for Complicated Hypertension (RDNP-2012-03)

Hypertension

Australia
Baker Heart and Diabetes Institute

Terminated

The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication

Peripheral Arterial Disease | Intermittent Claudication

Australia
HealthPartners Institute
Abbott Diabetes Care

Completed

Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes

Diabetes | Glucose Variability | CGM

United States
International Diabetes Institute, Australia
GlaxoSmithKline

Completed

GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets (GIANT)

Type 2 Diabetes Mellitus

China, Indonesia, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam
University of Alberta
Alberta Health services; Institute of Health Economics, Canada; University Hospital...

Recruiting

Midodrine for the Early Liberation of Vasopressor Support in the ICU (LIBERATE Multi-Site)

Vasoplegia

Canada
University of Alberta
Alberta Heritage Foundation for Medical Research; Institute of Health Economics...

Completed

A Cluster Randomized Trial to Assess the Impact of Opinion Leader Endorsed Evidence Summaries on Improving Quality of Prescribing for Patients With Chronic Cardiovascular Disease

Heart Failure | Coronary Disease | Ischemic Heart Disease

Canada
Baker Heart and Diabetes Institute

Recruiting

Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

Heart Failure

Australia
Baker Heart and Diabetes Institute

Completed

Sympathetic Nervous System Inhibition for the Treatment of Diabetic Kidney Disease

Diabetic Nephropathies

Australia
Baker Heart and Diabetes Institute

Completed

Renal Denervation to Improve Outcomes in Patients With End-stage Renal Disease

Hypertension | End-stage Renal Disease

Australia
Baker Heart and Diabetes Institute

Completed

Sham Controlled Clinical Trial of Renal Denervation in Patients With Resistant Hypertension

Hypertension

Australia
Dasman Diabetes Institute
Kuwait University

Active, not recruiting

Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric Surgery

Morbid Obesity | Type2 Diabetes
Baker Heart and Diabetes Institute

Withdrawn

Renal Denervation for Uncontrolled Hypertension (RDNP-2012-02)

Hypertension
Baker Heart and Diabetes Institute

Terminated

Renal Denervation for Resistant Hypertension (RDNP-2012-01)

Hypertension

Australia
Baker Heart and Diabetes Institute

Completed

Polycystic Ovary Syndrome - Improving Outcomes

Polycystic Ovary Syndrome

Australia
HealthPartners Institute
Abbott Diabetes Care

Completed

Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition (REACT4)

Diabetes Mellitus, Type 2 | Diabetic Blood Glucose Monitoring

United States
Baker Heart and Diabetes Institute

Unknown

Study of the Effect of Moxonidine and Diet on Sympathetic Functions in Young Adults With Obesity

Obesity | Overweight

Australia

Clinical Trials Sponsored by Alberta Diabetes Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations